ICYMI: SENATOR CORNYN DELIVERS REMARKS ON U.S. SENATE PASSAGE OF PATENT THICKET CRACKDOWN
Jul 15, 2024
Lawmakers Unanimously Advance Bipartisan Solution to Help Hold Big Pharma… Read More
© 2024 CSRXP- All Rights Reserved
News & Highlights
ICYMI: CSRxP JOINS MORE THAN 50 ORGANIZATIONS CALLING ON THE U.S. SENATE TO PASS BIPARTISAN SOLUTIONS TO CRACK DOWN ON BIG PHARMA’S PATENT ABUSE
Nov 2, 2023
Broad-based Coalition of Advocates, Including AARP and Patients for Affordable… Read More
ICYMI: Business Insider: “Big Pharma’s Big Tax Dodge”
Aug 9, 2023
International Experts Slam Big Pharma’s Egregious Offshoring Scam of U.S. Read More
ICYMI: THE COST OF BIG PHARMA’S EGREGIOUS PATENT ABUSE ON BRAND NAME INHALERS
Jun 2, 2023
Physicians Highlight How Big Pharma Games the System to Boost Profits and… Read More
ICYMI: LAWMAKERS MAKE BIPARTISAN CALL FOR FURTHER ACTION TO CRACK DOWN ON BIG PHARMA’S PATENT THICKETS
Mar 28, 2023
Members of Congress Send Letter Encouraging USPTO to Close Loopholes Exploited… Read More
ICYMI: I-MAK: Cracking Down on Big Pharma’s Patent Abuse to Lower Drug Prices Should Be Bipartisan Priority
Jan 27, 2023
Non-Profit Advocates for Affordable Prescription Drug Prices Call on Congress… Read More
ICYMI: STUDY FINDS MEDICARE PART B WOULD HAVE SAVED $3.7 BILLION OVER THREE YEARS IF BIG PHARMA’S PRICE HIKES WERE BELOW THE RATE OF INFLATION
Jan 9, 2023
Analysis Finds Drug Companies Increased Prices Faster Than the Rate of… Read More
ICYMI: WHAT COMES NEXT AFTER MAJOR STEP FORWARD ON DRUG PRICING
Sep 19, 2022
What Comes Next After Major Step Forward on Drug Pricing Real Clear Health… Read More
ICYMI: OPINION: DRUG COMPANIES ARE WARNING THAT PRICING REFORM SPELLS DOOM. DON’T FALL FOR IT
Aug 8, 2022
Washington Post Op-ed Debunks Bogus Big Pharma Claims That Solutions to Lower… Read More
ICYMI: CIVICASCRIPT BRINGS FIRST GENERIC DRUG TO MARKET TO PROVIDE MORE AFFORDABLE ALTERNATIVE TO HIGH-PRICED BIG PHARMA PRODUCTS
Aug 3, 2022
Private Sector and Non-Profit Partners Introduce Cancer Treatment That Can… Read More
ICYMI: USPTO, FDA ANNOUNCE PLAN TO CRACK DOWN ON BIG PHARMA’S PATENT ABUSE
Jul 19, 2022
Joint Effort Aims to Curb Anti-Competitive Tactics Used by Brand Name Drug… Read More
ICYMI: CBO FINDS HOLDING BIG PHARMA ACCOUNTABLE FOR ANTI-COMPETITIVE TACTICS WOULD SAVE BILLIONS OF DOLLARS
Jun 8, 2022
Scoring Shows Solutions to Crack Down on Branded Drug Companies’… Read More